Determination of fetal DNA fraction from the plasma of pregnant women using sequence read counts
- 3 June 2015
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 35 (8), 810-815
- https://doi.org/10.1002/pd.4615
Abstract
This study introduces a novel method, referred to as SeqFF, for estimating the fetal DNA fraction in the plasma of pregnant women and to infer the underlying mechanism that allows for such statistical modeling.Autosomal regional read counts from whole-genome massively parallel single-end sequencing of circulating cell-free DNA (ccfDNA) from the plasma of 25 312 pregnant women were used to train a multivariate model. The pretrained model was then applied to 505 pregnant samples to assess the performance of SeqFF against known methodologies for fetal DNA fraction calculations.Pearson's correlation between chromosome Y and SeqFF for pregnancies with male fetuses from two independent cohorts ranged from 0.932 to 0.938. Comparison between a single-nucleotide polymorphism-based approach and SeqFF yielded a Pearson's correlation of 0.921. Paired-end sequencing suggests that shorter ccfDNA, that is, less than 150 bp in length, is nonuniformly distributed across the genome. Regions exhibiting an increased proportion of short ccfDNA, which are more likely of fetal origin, tend to provide more information in the SeqFF calculations.SeqFF is a robust and direct method to determine fetal DNA fraction. Furthermore, the method is applicable to both male and female pregnancies and can greatly improve the accuracy of noninvasive prenatal testing for fetal copy number variation. © 2015 John Wiley & Sons, Ltd.Keywords
Funding Information
- Sequenom, Inc.
This publication has 22 references indexed in Scilit:
- The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidiesPrenatal Diagnosis, 2013
- Clinical application of massively parallel sequencing‐based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11 105 pregnancies with mixed risk factorsPrenatal Diagnosis, 2012
- Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic lociPrenatal Diagnosis, 2012
- Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18American Journal of Obstetrics and Gynecology, 2012
- DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation studyGenetics in Medicine, 2011
- Optimal Detection of Fetal Chromosomal Abnormalities by Massively Parallel DNA Sequencing of Cell-Free Fetal DNA from Maternal BloodClinical Chemistry, 2011
- Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the FetusScience Translational Medicine, 2010
- Quantification of Fetal DNA by Use of Methylation-Based DNA DiscriminationClinical Chemistry, 2010
- Personalized copy number and segmental duplication maps using next-generation sequencingNature Genetics, 2009
- Digital PCR for the molecular detection of fetal chromosomal aneuploidyProceedings of the National Academy of Sciences of the United States of America, 2007